Filter By Industry
Filter By Tag

Newsroom

Lavenhill Securities Limited Press releases

11 - 11 of 11 Press Releases

Bristol Myers Squibb Buys RayzeBio, Second Billion-Dollar Offer in Days. - Lavenhill Securities
Jan 11, 2024
RayzeBio Inc. (RYZB) shares soared Tuesday after Bristol Myers Squibb Co. (BMY) announced a $4.1 billion acquisition of the radiopharmaceutical therapy business to extend its cancer treatment choices.


Page: Prev 1 2
Lavenhill Securities Limited RSS Feed